About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 72722 record(s)
Req # A-2019-000270
Adverse Drug Reactions (ADRs). Report numbers: 000146129, 000191438, 000335588, 000335771, 000338151, 000345474, 00389283, 000390319, 000593310, E2B_00570261, E2B_00570262, E2B_00570263, E2B_00570264.Organization: Health Canada
February 2024
Req # A-2020-000388
Adverse Drug Reactions (ADRs). Report numbers: E2B_02731350, E2B_02777680, E2B_02810755, E2B_02838946, E2B_02852030, E2B_02856401, E2B_02777244, 000735201, E2B_02869967, E2B_02869987, E2B_02869946, E2B_02871897, E2B_02871900, E2B_02871882,…Organization: Health Canada
February 2024
Req # A-2020-000647
Adverse Drug Reactions (ADRs) for PANTOPRAZOLE. Report numbers: 000736259, 000738096, 000911912, E2B_02993730, E2B_03001785, E2B_03004317, E2B_03005410, E2B_03015111, E2B_03020794, E2B_03024205, E2B_03034122, E2B_03038830, E2B_03047792. ADRs for…Organization: Health Canada
February 2024
Req # A-2020-000731
Adverse Drug Reactions (ADRs) for Estrogel. Report numbers: 000693076, E2B_002778333. ADR for Ezetrol. Report number: E2B_01181304. ADRs for Fosamax. Report numbers: 000675450, 00685185, E2B_00037382, 000518360, 000555402, 000543195, E2B_00256053,…Organization: Health Canada
February 2024
Req # A-2020-000800
Adverse Drug Reactions (ADRs) for Fosamax. Report numbers: E2B_00498826, E2B_00498902, E2B_00500827, E2B_00506460, E2B_00786970, E2B_00894613, E2B_00894617, E2B_00894629, E2B_00896465, E2B_00898784, E2B_00898796, E2B_00898918, E2B_00941125,…Organization: Health Canada
February 2024
Req # A-2020-000870
Adverse Drug Reactions (ADRs). Report numbers: E2B_01674763, E2B_02137119, 000723810, 000724215, 000724308, 000724654, 000724751, E2B_02429833, E2B_02438547, E2B_02304224, E2B_02304226, E2B_02359312.Organization: Health Canada
February 2024
Req # A-2020-001098
Adverse Drug Reactions (ADRs). Report numbers: E2B_02122343, E2B_02124829, E2B_02125454, E2B_02124823, E2B_02198090, E2B_02174028, E2B_02198927, E2B_02251024, E2B_02262610, E2B_02268152,E2B_02236011, E2B_02302657, E2B_02312268, E2B_02272665,…Organization: Health Canada
February 2024
Req # A-2020-001185
Adverse Drug Reactions (ADRs). Report numbers: E2B_02432721, E2B_02432728, E2B_02432900, E2B_02432947, E2B_02433003, E2B_02433242, E2B_02433328, E2B_02433386, E2B_02434051, E2B_02434786, E2B_02435446, E2B_02435609, E2B_02435740, E2B_02436225,…Organization: Health Canada
February 2024
Req # A-2020-001227
Adverse Drug Reactions (ADRs). Report numbers: E2B_02538249, E2B_02538715, E2B_02538723, E2B_02539929, E2B_02539930, E2B_02540245, E2B_02541195, E2B_02541203, E2B_02541612, E2B_02541907, E2B_02542078, E2B_02543068, E2B_02543070, E2B_02543071,…Organization: Health Canada
February 2024
Req # A-2020-001302
Adverse Drug Reactions (ADRs). Report numbers: E2B_02752753, E2B_02752996, E2B_02753018, E2B_02753810, E2B_02753956, E2B_02754001, E2B_02754101, E2B_02754220, E2B_02754403, E2B_02755220, E2B_02755268, E2B_02755285, E2B_02755302, E2B_02755332,…Organization: Health Canada
February 2024